The Quest to Beat Aging
Two humans that want to live a thousand years are the presidents of China and Russia. In September 2025, they were overheard talking about using organ transplants to extend their lives indefinitely. As a strategy, organ transplants have major shortcomings: it can be hard to find the organs, and just as hard to stop our immune systems from rejecting them. But people have invested billions of dollars in developing other approaches. Learn more about those listed below, then discuss with your team: if science does find ways for us to live much longer lives, would there be any reason to hesitate before using them?
- organoids | bioprinting | plasma transfusion | senotherapeutics
- cellular reprogramming | cellular rejuvenation | telomere extension
- caloric restriction | digital immortality | cryonics
In September 2025, the presidents of China and Russia were overheard musing that repeated organ transplants might let a person 'get younger and younger' and hold off old age 'indefinitely.' Behind that eavesdropped wish sits a real, multibillion-dollar race to defeat aging itself — by a dozen very different routes.
Key concepts
- Aging As A Treatable Process
- The reframing at the heart of longevity science: aging isn't fixed destiny but a set of biological breakdowns that might be slowed, halted, or reversed — turning 'getting old' from fate into a medical target.
- Repair Versus Rejuvenation
- Two strategies — repairing the damage aging causes (new organs, clearing worn-out cells) versus resetting cells to a younger state; one patches the body, the other turns back its clock.
- Access And Inequality
- If radical longevity is expensive, it could become the ultimate privilege — the wealthy buying decades the rest can't, hardening inequality into a literal difference in lifespan.
- Generational Turnover
- Societies renew as people age out and new generations take over — if leaders could live indefinitely, that turnover stalls, raising the prospect of frozen power.
What to know
-
01
The transplant idea Xi and Putin discussed runs into known walls — organs are scarce and the immune system rejects them — which is why money flows to bioprinting and reprogramming, attempts around the very limits that conversation ignored.
Keep reading the full lesson
The rest of this lesson — every key insight, the cross-subject connection, the Are We There Yet? theme tie-in, and practice questions — comes with full access.
Unlock full access →$9.99/month, or $29.99 for the whole season — see plans.
New here? Create a free account to read the free section first.